Arsenal Capital Partners, a private equity firm specializing in building healthcare businesses, today announced the acquisition of Zipher Medical Affairs, a leading provider of expert medical affairs strategic consulting services in the United States.
A well-planned and comprehensive data generation program will provide you with the tools you need to be successful in preparing for launch and beyond.
Insights provide the ability to gain a clear, deep, and sometimes unexpected understanding of a complicated problem or situation. In the pharmaceutical arena, insights are external trends that are actionable and have the potential to alter medical strategy
An effective program management system with well-designed project trackers, dashboards and project management support can accelerate your launch strategy.
Medical Affairs (MA) serves as a core scientific voice for the organization. With high competition and limited budget, it has grown increasingly more critical for Medical to meet their goals and key milestones at year-end.
As we celebrate our 12th Anniversary, we'd like to share the top 12 Medical Affairs tips every life science company should implement to ensure successful outcomes!
During this episode of Medical Affairs unscripted, Dr. Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of Medical Affairs (MA) organizations and how MA can move closer to being identified as a strategic pillar within the life sciences industry alongside the Research & Development and Commercial organizations.
During this webcast, you will learn from industry experts Peg Crowley-Nowick, PhD, MBA President of Zipher Medical Affairs Co., LLC. and Christopher Keir, MD, MS as they share key strategies for an effective and efficient approach to success in launch preparation.
In this episode of Medical Affairs unscripted, President and Founder Peg Crowley-Nowick has a conversation with Dan Hennessy. They discuss reaching the right stakeholders, who they are, how important it is to engage and have scientific exchange, and what the risks are for not doing this well.
Virtual meetings and video conferencing have become integrated into our business, but we are now utilizing these platforms on a new scale. Although these tools allow us to stay connected from almost any location, we also need to stay engaged...
